Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney disease

Abstract Background Ferritin levels are used to make decisions on therapy of iron deficiency in patients with chronic kidney disease (CKD). Hyperferritinaemia, common among patients with CKD from the Northern Territory (NT) of Australia, makes use of ferritin levels as per clinical guidelines challe...

Full description

Bibliographic Details
Main Authors: Sandawana William Majoni, Jane Nelson, Jessica Graham, Asanga Abeyaratne, David Kiran Fernandes, Sajiv Cherian, Geetha Rathnayake, Jenna Ashford, Lynn Hocking, Heather Cain, Robert McFarlane, Paul Damian Lawton, Federica Barzi, Sean Taylor, Alan Cass
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Nephrology
Online Access:https://doi.org/10.1186/s12882-023-03255-6